COVID-19 CPT testing codes
Horizon BCBSNJ is prepared to accept the following codes based on Horizon BCBSNJ’s policies and procedures:
| Code | Description |
| U0001 | CDC testing laboratories to test patients for SARS-CoV-2 |
| U0002 | Non-CDC laboratory tests for SARS-CoV-2/2019-nCoV (COVID-19) |
| U0003 | Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies as described by CMS-2020-01-R. |
| U0004 | 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies as described by CMS-2020-01-R. |
| 86328 | Immunoassay for infectious agent antibody(ies), qualitative or semi-qualitative, single step method (e.g., reagent strip): severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); Represents a simple single-step test, often used as a point-of-care test, that could be done in a physician office setting (Coverage in adults requires evidence for an individualized clinical assessment based on CDC recommendations.) |
| 86769 | Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); Represents a multi-step method test, likely to be done by an independent lab or hospital (Coverage in adults requires evidence for an individualized clinical assessment based on CDC recommendations.) |
| 87635 | Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique |
| 99000 | Handling and/or conveyance of specimen for transfer from the office to a laboratory |
| 99001 | Handling and/or conveyance of specimen for transfer from the patient in other than an office to a laboratory (distance may be indicated) |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), any specimen source (Billable by clinical diagnostic laboratories.) |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), from an individual in a skilled nursing facility or by a laboratory on behalf of a home health agency, any specimen source (Billable by clinical diagnostic laboratories.) |